New appointment at Apposite Capital
This article was originally published in Scrip
Apposite Capital (UK), an investment firm focused on healthcare, has appointed Dr Eric Shiozaki associate director, North America. He will be based in San Francisco and will support the company's investments activities in North America. He most recently worked at Burrill & Company, where he helped make and manage new investments. Before that, Mr Shiozaki worked in technology transfer at the University of California, where he managed a portfolio of healthcare technologies.
You may also be interested in...
The Phase III FIDELIO trial of finerenone has been a success but analysts want to see some actual data before declaring it an unqualified one.
Gilead says remdesivir improved mortality and clinical recovery in COVID-19 patients, but the findings come from a retrospective analysis, not a traditional clinical trial.
Agency resuming domestic inspections with the help of a pandemic rating system to identify localities where inspections will be safest for investigators and plant workers. Another safety factor: all inspections will be pre-announced.